These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 1542474)

  • 1. The clinical associations with hepatic steatosis: a retrospective study.
    Samarasinghe D; Tasman-Jones C
    N Z Med J; 1992 Feb; 105(928):57-8. PubMed ID: 1542474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol.
    Monto A; Alonzo J; Watson JJ; Grunfeld C; Wright TL
    Hepatology; 2002 Sep; 36(3):729-36. PubMed ID: 12198667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The natural history of nonalcoholic fatty liver: a follow-up study.
    Teli MR; James OF; Burt AD; Bennett MK; Day CP
    Hepatology; 1995 Dec; 22(6):1714-9. PubMed ID: 7489979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Steatosis and nonalcoholic steatohepatitis. A comparative analysis].
    Piñol V; Bessa X; Bruguera M; Rodés J
    Gastroenterol Hepatol; 2000 Feb; 23(2):57-61. PubMed ID: 10726383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis.
    Contos MJ; Cales W; Sterling RK; Luketic VA; Shiffman ML; Mills AS; Fisher RA; Ham J; Sanyal AJ
    Liver Transpl; 2001 Apr; 7(4):363-73. PubMed ID: 11303298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.
    Angulo P; Keach JC; Batts KP; Lindor KD
    Hepatology; 1999 Dec; 30(6):1356-62. PubMed ID: 10573511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-alcoholic fatty liver disease in liver transplant recipients: another story of "seed and soil".
    Dumortier J; Giostra E; Belbouab S; Morard I; Guillaud O; Spahr L; Boillot O; Rubbia-Brandt L; Scoazec JY; Hadengue A
    Am J Gastroenterol; 2010 Mar; 105(3):613-20. PubMed ID: 20040915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steatosis in donor and transplant liver biopsies.
    Crowley H; Lewis WD; Gordon F; Jenkins R; Khettry U
    Hum Pathol; 2000 Oct; 31(10):1209-13. PubMed ID: 11070113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors for pure steatosis in alcoholic patients.
    Naveau S; Thaury J; Barri-Ova N; Balian A; Dauvois B; Njiké-Nakseu M; Prévot S; Agostini H; Perlemuter G
    Alcohol Clin Exp Res; 2009 Jun; 33(6):1104-10. PubMed ID: 19382900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
    Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nonalcoholic fatty liver hepatitis and fatty cirrhosis mimicking alcoholic liver diseases].
    Spech HJ; Liehr H; Mitschke H
    Z Gastroenterol; 1983 Nov; 21(11):651-9. PubMed ID: 6659631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steatosis as a predictive factor for treatment response in patients with chronic hepatitis C.
    Antúnez I; Aponte N; Fernández-Carbia A; Rodríguez-Perez F; Toro DH
    P R Health Sci J; 2004 Jun; 23(2 Suppl):57-60. PubMed ID: 16929588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological findings and clinical characteristics associated with hepatic steatosis in patients coinfected with HIV and hepatitis C virus.
    Marks KM; Petrovic LM; Talal AH; Murray MP; Gulick RM; Glesby MJ
    J Infect Dis; 2005 Dec; 192(11):1943-9. PubMed ID: 16267765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of hepatic steatosis on the natural history of chronic hepatitis C infection.
    Cross TJ; Quaglia A; Hughes S; Joshi D; Harrison PM
    J Viral Hepat; 2009 Jul; 16(7):492-9. PubMed ID: 19200134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Obesity: risk factor for steatohepatitis and hepatic fibrosis].
    Poniachik J; Mancilla C; Contreras J; Csendes A; Smok G; Cavada G; Rojas J; Oksenberg D; Burdiles P; Maluenda F; Díaz JC
    Rev Med Chil; 2002 Jul; 130(7):731-6. PubMed ID: 12235896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors for the severity of liver fibrosis in patients with chronic hepatitis C and moderate alcohol consumption.
    Vădan R; Gheorghe L; Becheanu G; Iacob R; Iacob S; Gheorghe C
    Rom J Gastroenterol; 2003 Sep; 12(3):183-7. PubMed ID: 14502317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic steatosis in genotype 4 chronic hepatitis C is mainly because of metabolic factors.
    Tsochatzis E; Papatheodoridis GV; Manesis EK; Chrysanthos N; Kafiri G; Petraki K; Hadziyannis E; Pandelidaki H; Zafiropoulou R; Savvas S; Koskinas J; Archimandritis AJ
    Am J Gastroenterol; 2007 Mar; 102(3):634-41. PubMed ID: 17222326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrum of histological features in non-alcoholic fatty liver disease.
    Vasdev N; Kakati AG; Saigal S; Nayak NC
    Natl Med J India; 2007; 20(6):282-7. PubMed ID: 18335793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duodenal switch has no detrimental effects on hepatic function and improves hepatic steatohepatitis after 6 months.
    Keshishian A; Zahriya K; Willes EB
    Obes Surg; 2005; 15(10):1418-23. PubMed ID: 16354521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.